10-QPeriod: Q3 FY2008

UNITEDHEALTH GROUP INC Quarterly Report for Q3 Ended Sep 30, 2008

Filed November 7, 2008For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) reported third-quarter 2008 results reflecting continued revenue growth driven by its Health Care Services segment, largely due to acquisitions and increased enrollment in senior and public markets. However, earnings from operations and net earnings declined year-over-year, impacted by increased medical costs and operating expenses, including significant legal settlements related to historical stock option practices. The company also noted a decrease in cash and cash equivalents compared to the previous year, though it maintained substantial investment balances. Strategic acquisitions, notably Sierra Health Services and Fiserv Health, bolstered segment revenues and expanded market reach, particularly in the Southwest and PBM services respectively. Despite a challenging economic environment, UNH emphasized its robust liquidity and financial flexibility, supported by strong operating cash flows and available credit facilities. The company continues to manage its capital structure through share repurchases and debt management. Significant legal proceedings related to stock option practices are nearing resolution with proposed settlements, which have impacted recent financial results. Investors should note the increased medical care ratio and operating cost ratio, which put pressure on margins, alongside ongoing efforts to manage healthcare cost inflation.

Financial Highlights

31 data points
Beta

Revenue

$20.16B

98.1% Gross Margin

Net Income

$920.00M

4.6% Net Margin

EPS (Diluted)

$0.75

Cash & Equivalents

$6.08B

Free Cash Flow

$1.57B

Financial Statements
Beta
Revenue$20.16B
Cost of Revenue$387.00M
Gross Profit$19.77B
SG&A Expenses$2.97B
Operating Expenses$18.56B
Operating Income$1.60B
Interest Expense$166.00M
Net Income$920.00M
EPS (Basic)$0.76
EPS (Diluted)$0.75
Shares Outstanding (Basic)1.20B
Shares Outstanding (Diluted)1.23B

Key Highlights

  • 1Consolidated revenues increased by 8% to $20.2 billion in Q3 2008, driven by Health Care Services and acquisitions.
  • 2Diluted net earnings per common share decreased by 21% to $0.75 in Q3 2008 compared to the prior year.
  • 3Acquisitions of Sierra Health Services, Fiserv Health, and Unison Health Plans contributed to revenue growth and expanded market presence.
  • 4Significant legal settlements related to historical stock option practices resulted in pre-tax costs of $882 million for the nine months ended September 30, 2008.
  • 5Cash and cash equivalents decreased to $6.1 billion from $8.9 billion at the end of 2007, while total cash, cash equivalents, and investments remained substantial at $20.4 billion.
  • 6The consolidated medical care ratio increased to 81.7% in Q3 2008 from 79.5% in Q3 2007, indicating higher medical costs relative to premium revenues.
  • 7Despite a decrease in earnings, the company maintained a strong liquidity position with $20.4 billion in cash, cash equivalents, and investments.

Frequently Asked Questions

Revenue growth was primarily driven by the Health Care Services segment, fueled by acquisitions such as Sierra Health Services and Fiserv Health, as well as increased enrollment in senior and public market plans. Overall consolidated revenues increased by 8% to $20.2 billion.

Net earnings per share decreased by 21% to $0.75 due to several factors, including a higher medical care ratio (81.7% vs. 79.5%), increased operating costs, and significant pre-tax costs of $882 million related to the settlement of class action lawsuits concerning historical stock option practices. These factors put pressure on overall profitability.

Cash and cash equivalents decreased to $6.1 billion from $8.9 billion at the end of 2007. However, total cash, cash equivalents, and investments remained strong at $20.4 billion. Primary sources of liquidity include cash flows from operations, a substantial investment portfolio, and available credit facilities. The company emphasizes its financial flexibility despite challenging market conditions.

The increase in the consolidated medical care ratio to 81.7% indicates that medical costs are growing at a faster rate than premium revenues. This was attributed to factors like lower-than-anticipated risk-adjusted revenue yields in certain Medicare products, gross margin pressures, and competitive pricing environments where premium increases did not fully offset rising medical costs.